Bloomberg Law consulted several healthcare investment experts and obtained a list of deals announced or closed this year from investment bankers ECG Management Consultants and Provident Healthcare Partners.
Five takeaways:
1. A whopping 111 healthcare industry deals transpired in January, 85 each in February and March, and 83 in April.
2. Investor-driven platforms are increasingly striking deals with physician practices.
3. Strong consolidation candidates include practices specializing in ophthalmology, dermatology, orthopedics, gastroenterology, radiology, urology, OB-GYN, vein surgery or primary care. Dermatology deals are especially attractive to investors.
4. The hospital and health system sector saw a major drop in transaction activity after the first quarter.
5. Hospitals in mid-America are taking a serious look at their strategic options for long-term viability, so the hospital and health system sector may be the exception to stronger deal volume in the second half of the year.
More articles on surgical centers:
13 physicians join 3-way joint venture for orthopedics-focused ASC in Missouri: 5 key notes
What the rise in high-deductible health plans means for ASCs
The 3 revenue cycle benchmarks ASCs should track
